Ensuring diversity in a Large Type II diabetes study
SubjectWell’s targeted recruitment strategy ensured a diverse and representative patient population for a large Type 2 diabetes study, surpassing diversity goals for patients over 65 and increasing Black patient enrollment beyond expectations.
New FMLA Guidance Empowers Patients to Participate in Clinical Trials
New FMLA guidance now protects job security for patients participating in clinical trials, removing a major barrier to accessing innovative treatments.
SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities
Austin, TX, September 17, 2024 — SubjectWell, provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform, is pleased to announce its acquisition of Trials24, a renowned provider of global digital patient recruitment solutions. This strategic acquisition will enhance SubjectWell’s ability to connect patients to transformative healthcare across all geographies. The […]
How medical contact centers power patient recruitment for clinical trials
Behind every successful patient recruitment strategy is a well-trained medical contact center. From building patient trust to ensuring HIPAA-compliant communication, contact centers are critical for screening, education, and long-term engagement in clinical trials.
3 in 4 surveyed patients show strong interest in replacing medications with both approved and experimental treatments.
This growing openness offers a valuable opportunity for sponsors and CROs to engage motivated participants if recruitment strategies are aligned with patient motivations and trust.
WindRose Health Investors Completes Majority Growth Investment in SubjectWell
New York, NY, April 30, 2024 — WindRose Health Investors, LLC, (“Windrose”) the New York-based healthcare private equity firm, announced that it has completed the acquisition of SubjectWell, the patient access marketplace that connects people with health conditions to care options. The terms of the transaction were not disclosed. Using a multi-channel network and precision […]
SubjectWell Receives System and Organization Controls (SOC) 2 Type 2 Certification
The patient access marketplace successfully demonstrated strong data security credentials throughout comprehensive assessment. AUSTIN, TX, November 14, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced it has received its System and Organization Controls (SOC) 2 Type 2 certification, a voluntary compliance standard which […]
SubjectWell Acquires PatientCentra
Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications AUSTIN, TX, November 2, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers […]
Why HCP outreach is so important for recruiting patients in rare disease
In rare disease trials, where patients are few and diagnosis is complex, trusted healthcare providers play a critical role in bridging the gap. This blog explores why HCP outreach is a powerful and often overlooked tool for patient recruitment, and how it can drive more qualified referrals and meaningful engagement.
